Table 1.
Baseline characteristics of subjects in the study
| Group | N | Age | PD duration | UPDRS M | UPDRS T | Free T | Total T | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | ||
| Pramipexole | 12 | 68.83 | 13.13 | 2.44 | 1.67 | 21.92 | 5.62 | 30.75 | 8.25 | 63.69 | 25.24 | 386.32 | 151.73 |
| Levodopa | 9 | 70.33 | 9.31 | 2.11 | 1.45 | 17.44 | 7.09 | 25.22 | 10.51 | 55.03 | 18.18 | 361.06 | 146.71 |
| NoTreatment | 11 | 60.36 | 6.55 | 2.1 | 1.6 | 17.91 | 8.23 | 26.09 | 11.41 | 89.54 | 29.88 | 449.55 | 134.92 |
Legend: UPDRS M- Unified Parkinson Disease Rating Scale Motor Subsection, UPDRS T- Unified Parkinson Disease Rating Scale total score. Free T - free testosterone level; Total T - total testosterone level.